AACR 2 Virtual Meeting, 22–24 June 2020

A Phase I study of BI 754111, an anti-LAG-3 mAb, in combination with BI 754091, an anti-PD-1 mAb: biomarker analyses from the microsatellite stable metastatic colorectal cancer cohort

Johanna Bendell, Susanna V. Ulahannan, Quincy Chu, Manish R. Patel, Ben George, Aurélie Auguste, Theresia Leo-Kress, Kai Bernd Stadermann, Nicole Kraemer, Mabrouk Elgadi, Melissa Johnson

Bendell_1381.2 biomarker poster_AACR 2020
Methods: biomarker analyses
Methods: biomarker analyses
Methods: biomarker analyses (cont’d)
Results
References

Related Materials

Learn more about the science behind this poster in the videos, papers and other materials below.

 

 

AACR-NCI-EORTC Congress 2019: A Phase I, dose finding study of BI 754111, an anti-LAG-3 antibody, in combination with BI 754091, an anti-PD-1 antibody, in patients with advanced solid tumors: preliminary results from the microsatellite stable metastatic colorectal cancer cohort

Johanna Bendell, Susanna V Ulahannan, Quincy Chu, Manish Patel, Ben George, Mabrouk Elgadi, Christine Duffy, Ralph Graeser, Wenbo Tang, Michael Merger, Miaomiao Ge, Melissa Johnson

Bendell_1381.2 CRC_AACR-NCI-EORTC 2019

FOR HEALTHCARE PROFESSIONALS ONLY

links_to_3rd_party.jpg